H.R. 5381 · 116th Congress
International Pharmaceutical Transparency Act of 2019
- Stage
- In committee
- Sponsor
- Scott DesJarlais
- Introduced
- 2019-12-10
- Latest action
- 2019-12-11 · Referred to the Subcommittee on Health.
Summary
International Pharmaceutical Transparency Act of 2019
This bill prohibits the sale of a drug if its label fails to list the country of origin of each of the drug's active ingredients.